Molecular basis of drug interaction with L-type Ca2+ channels

Journal of Bioenergetics and Biomembranes

Volumn 30, Issue 4, 1998, Pages 319-334

  Mitterdorfer, Jörg ^a   Grabner, Manfred ^a   Kraus, Richard L ^a   Hering, Stoffen ^a   Prinz, Heino ^b   Glossmann, Hartmut ^a   Striessnig, Jörg ^a  

^a A 6020   (Austria)

^b MAX PLANCK INSTITUTE OF MOLECULAR PHYSIOLOGY   (Germany)

Author keywords

Calcium channel blockers; Dihydropyridines; Drug binding domains; Ion channels; Mutagenesis

Indexed keywords

CALCIUM CHANNEL; CALCIUM CHANNEL BLOCKING AGENT; DIHYDROPYRIDINE DERIVATIVE;

CELL SECRETION; CEREBROVASCULAR ACCIDENT; DRUG BINDING; DRUG DESIGN; EXCITATION CONTRACTION COUPLING; GENE MUTATION; HYPERTENSION; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PROTEIN EXPRESSION; SHORT SURVEY; STRUCTURE ACTIVITY RELATION;

AFFINITY LABELS; ALLOSTERIC REGULATION; ALLOSTERIC SITE; AMINO ACID SEQUENCE; ANIMALS; ANTIBODY SPECIFICITY; ANTIHYPERTENSIVE AGENTS; BINDING SITES; CALCIUM; CALCIUM CHANNEL BLOCKERS; CALCIUM CHANNELS; CALCIUM CHANNELS, L-TYPE; CALCIUM SIGNALING; DRUG DESIGN; EPITOPES; HUMANS; ION CHANNEL GATING; MODELS, BIOLOGICAL; MOLECULAR SEQUENCE DATA; MUTAGENESIS, SITE-DIRECTED; PROTEIN BINDING; PROTEIN CONFORMATION; RECOMBINANT FUSION PROTEINS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0031719884     PISSN: 0145479X     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1021933504909     Document Type: Short Survey

References (89)

1. Bean, B. P. (1984). "Nitrendipine block of cardiac calcium channels: high-affinity binding to the inactivated state," Proc. Natl. Acad. Sci. USA 81, 6388-6392.
2. 3H]-Nitrendipine, a potent calcium antagonist, binds with high affinity to cardiac membranes," Arzeimittelforschung 31, 2064-2067.
3. 2+ channels," Brit. J. Pharmacol. 119, 1197-1202.
4. 2+ channel antagonist mibefradil (Ro 40-5967)," Mol. Pharmacol. 48, 540-549.
5. Boer, R., Dichtl, M., Borchers, C., Ulrich, W. R., Marecek, J. F., Prestwich, G. D., Glossmann, H., and Striessnig, J. (1996). "Reversible labeling of a chemosensitizer binding domain of P-glycoprotein with a novel 1,4-dihydropyridine drug transport inhibitor," Biochemistry 35, 1387-1396.
6. Brauns, T., Cai, Z.-W., Kimball, D., Kang, H.-C., Haugland, R. P., Berger, W., Berjukov, S., Hering, S., Glossmann, H., and Striessnig, J. (1995). "Benzothiazepinone binding domain of purified L-type calcium channels: direct labeling using a novel fluorescent diltiazem analogue," Biochemistry 34, 3461-3469.
7. Brauns, T., Prinz, H., Kimball, S. D., Haugland, R. P., Striessnig, J., and Glossmann, H. (1997). "L-type calcium channels: binding domains for dihydropyridines and benzothiazepines are located in close proximity to each other," Biochemistry 36, 3625-3631.
8. Castellano, A., Wei, X., Birnbaumer, L., and Perez-Reyes, E. (1993). "Cloning and expression of a neuronal calcium channel β subunit," J. Biol. Chem. 268, 12359-12366.
9. Catterall, W. A., and Striessnig, J. (1992). "Receptor sites for calcium antagonists," Trends Pharmacol. Sci. 13, 256-262.
10. 2+ channels," J. Biol. Chem. 270, 30036-30044.
11. Cunningham, B. C., and Wells, J. A. (1989). "High-resolution epitope mapping of hGH-receptor interactions by alanine-scanning mutagenesis," Science 244, 1081-1085.
12. Curtis, B. M., and Catterall, W. A. (1984). "Purification of the calcium antagonist receptor of the voltage-sensitive calcium channel from skeletal muscle transverse tubules," Biochemistry 23, 2113-2218.
13. Debry, P., Nash, E. A., Neklason, D. W., and Metherall, J. E. (1997). "Role of multidrug resistance P-glycoproteins in cholesterol esterification," J. Biol. Chem. 212, 1026-1031.
14. Dennis, M., Giraudat, J., Kotzyba-Hibert, F., Goeldner, M., Hirth, C., Chang, J., Lazure, C., Chrétien, M., and Changeux, J.-P. (1988). "Amino acids of the torpedo marmorata acetylcholine receptor alpha subunit labeled by a photoaffinity ligand for the acetylcholine binding site," Biochemistry 27, 2346-2357.
15. Döring, F., Degtiar, V. E., Grabner, M., Striessnig, J., Hering, S., and Glossmann, H. (1996). "Transfer of L-type calcium channel IVS6 segment increases phenylalkylamine sensitivity of alpha 1A," J. Biol. Chem. 271, 11745-11749.
16. + channel," Neuropharmacology 35, 761-773.
17. Felix, J. P., King, V. F., Shevell, J. L., Garcia, M. L., Kaczorowski, G. J., Bick, I. R. C., and Slaughter, R. S. (1992). "Bis(benzylisoquinoline) analogs of tetrandrine block L-type calcium channels: evidence for interaction at the diltiazem-binding site," Biochemistry 31, 11793-11800.
18. 2+ channels with [3H]azidopine," FEBS Lett. 169, 112-122.
19. Ferry, D. R., Goll, A., and Glossmann, H. (1987). "Photoaffinity labelling of the cardiac calcium channel," Biochem. J. 243, 127-135.
20. Ferry, D. R., Russell, M. A., and Cullen, M. H. (1992). "P-Glycoprotein possesses a 1,4-dihydropyridine-selective drug acceptor site which is allosterically coupled to a vinca-alkaloid-selective binding site," Biochem. Biophys. Res. Commun. 188, 440-445.
21. Fleckenstein, A. (1983). Calcium Antagonism in Heart and Smooth Muscle (Fleckenstein, A., ed.), Wiley, New York.
22. Glossmann, H., Ferry, D. R., Luebbecke, F., Mewes, R., and Hofmann, F. (1982). "Calcium channels: direct identification with radioligand binding studies," Trends Pharmacol. Sci. 3, 431-437.
23. Glossmann, H., and Striessnig, J. (1988). "Calcium channels," Vitam. Horm. 44, 155-328.
24. Glossmann, H., and Striessnig, J. (1990). "Molecular properties of calcium channels," Rev. Physiol. Biochem. Pharmacol. 114, 1-105.
25. Glossmann, H., Ferry, D. R., and Boschek, C. B. (1983a). "Purification of the putative calcium channel from skeletal muscle with the aid of [3H]-nimodipine binding," Naunyn-Schmiedeberg's Arch. Pharmacol. 323, 1-11.
26. 2+ channels by 1,4-dihydropyridine channel agonists and antagonists," FEBS Lett. 160, 226-232.
27. Glossmann, H., Ferry, D. R., Goll, A., Striessnig, J., and Zernig, G. (1985). "Calcium channels and calcium channel drugs: recent biochemical and biophysical findings," Drug Res. 35, 1917-1935.
28. Gould, R. J., Murphy, K. M. M., and Snyder, S. H. (1982). "[3H]nitrendipine-labeled calcium channels discriminate inorganic calcium agonists and antagonists," Proc. Natl. Acad. Sci. USA 79, 3656-3660.
29. Grabner, M., Wang, Z., Hering, S., Striessnig, J., and Glossmann, H. (1996). "Transfer of 1,4-dihydropyridine sensitivity from L-type to class A (BI) calcium channels," Neuron 16, 207-218.
30. Gross, A., Abramson, T., and MacKinnon, R. (1995). "Transfer of the scorpion toxin receptor to an insensitive potassium channel," Neuron 13, 761-766.
31. He, M., Bodi, I., Mikala, G., and Schwartz, A. (1997). "Motif III S5 of L-type calcium channels involved in the dihydropyridine binding site," J. Biol. Chem. 272, 2629-2633.
32. Hering, S., Savchenko, A., Strübing, C., Lakitsch, M., and Striessnig, J. (1993). "Extracellular localization of the benzothiazepine binding domain of L-type calcium channels," Mol. Pharmacol. 43, 820-826.
33. Hering, S., Aczel, S., Grabner, M., Döring, F., Berjukow, S., Mitterdorfer, J., Sinnegger, M. J., Striessnig, J., Degtiar, V. E., Wang, Z., and Glossmann, H. (1996). "Transfer of high sensitivity for benzothiazepines from L-type to class A(BI) calcium channels," J. Biol. Chem. 271, 24471-24475.
34. Hering, S., Aczel, S., Kraus, R. L., Berjukov, S., Striessnig, J., and Timin, E. N. (1997). "Molecular mechanism of use-dependent calcium channel block by phenylalkylamines: role of inactivation," Proc. Natl. Acad. Sci. USA, 94, 13323-13328.
35. Hescheler, J., Pelzer, D., Trube, G., and Trautwein, W. (1982). "Does the organic calcium channel blocker D600 act from inside or outside on the cardiac cell membrane," Pflügers Arch. 393, 287-291.
36. Hille, B. (1991). Ionic Channels of Excitable Membranes. (Hille, B., ed.),
37. Hockerman, G. H., Johnson, B. D., Scheuer, T., and Catterall, W. A. (1995). "Molecular determinants of high-affinity phenylalkylamine block of L-type calcium channels," J. Biol. Chem. 270, 22119-22122.
38. Hockerman, G. H., Johnson, B. D., Abbott, M. R., Scheuer, T., and Catterall, W. A. (1997a). "Molecular determinants of high-affinity phenylalkylamine block of L-type calcium channels in transmembrane segment IIIS6 and the pore region of the alpha 1 subunit," J. Biol. Chem. 272, 18759-18765.
39. Hockerman, G. H., Peterson, B. Z., Johnson, B. D., and Catterall, W. A. (1997b). "Molecular determinants of drug binding and action on L-type calcium channels," Annu. Rev. Pharmacol. Toxicol. 37, 361-396.
40. Hockerman, G. H., Peterson, B. Z., Sharp, E., Tanada, T. N., Scheuer, T., Catterall, W. A. (1997c). "Construction of a high-affinity receptor site for dihydropyridine agonists and antagonists by single amino acid substitutions in a non-L-type calcium channel. Proc. Natl. Acad. Sci. (USA) 94, 14906-14911.
41. 2+ channel diversity," Annu. Rev. Neurosci. 17, 399-418.
42. Isom, L. L., and Catterall, W. A. (1994). "Auxiliary subunits of voltage-gated ion channels," Neuron 12, 1183-1194
43. Ito, H., Klugbauer, N., and Hofmann, F. (1997). "Transfer of the high-affinity dihydropyridine sensitivity from L-type to non-L-type calcium channel," Mol. Pharmacol. 52, 735-740
44. Ji, H., Zheng, W., Zhang, Y., Catt, K. J., and Sandberg, K. (1995). "Genetic transfer of a nonpeptide antagonist binding site to a previously unresponsive angiotensin receptor," Proc. Natl. Acad. Sci. USA 92, 9240-9244.
45. Kass, R. S., Arena, J. P., and Chin, S. (1991). "Block of L-Type calcium channels by charged dihydropyridines," J. Gen. Physiol. 98, 63-75.
46. 2+ channels," J. Biol. Chem. 267, 2179-2189.
47. Kraus, R. L., Reichl, B., Kimball, S. D., Grabner, M., Murphy, B. J., Catterall, W. A., and Striessnig, J. (1996). "Identification of benz(othi)azepine binding regions within L-type calcium channel alpha 1 subunits." J. Biol. Chem. 271, 20113-20118.
48. Lacerda, A. E., Kim, H. S., Ruth, P., Perez-Reyes, E., Flockerzi, V., Hofmann, F., Birnbaumer, L., and Brown, A. M. (1991). "Normalization of current kinetics by interaction between the alpha 1 and beta subunits of the skeletal muscle dihydropyridine-sensitive calcium channel," Nature 352, 527-530.
49. Lakowicz, J. R. (1983). Principles of Fluorescence Spectroscopy, Plenum Press, New York.
50. 1-subunit," FEBS Lett. 352, 141-145.
51. 2+ channel alpha 1 subunit," Biochemistry 34, 9350-9355.
52. Mitterdorfer, J., Wang, Z., Sinnegger, M. J., Hering, S., Striessnig. J., Grabner, M., and Glossmann, H. (1996). "Two amino acid residues in the IIIS5 segment of L-type calcium channels differentially contribute to 1,4-dihydropyridine sensitivity," J. Biol. Chem. 271, 30330-30335.
53. 2+ antagonist binding protein from guinea-pig liver endoplasmic reticulum," J. Biol. Chem. 269, 29314-29320.
54. Moebius, F. F., Striessnig, J., and Glossmann, H. (1997). "The mysteries of sigma receptors: new family members reveal a role in cholesterol synthesis," Trends Pharmacol. Sci. 18, 67-70.
55. 3H]azidobutyryldiltiazern," J. Biol. Chem. 264, 21211-21214.
56. Nakayama, H., Taki, M., Striessnig, J., Glossmann, H., Catterall, W. A., and Kanaoka, Y. (1991). "Identification of 1,4-dihydropyridine binding regions within the alpha 1 subunit of skeletal muscle calcium channels by photoaffinity labeling," Proc. Natl. Acad. Sci. USA 88, 9203-9207.
57. Neely, A., Wei, X., Olcese, R., Birnbaumer, L., and Stefani, E. (1993). "Potentiation by the β Subunit of the ratio of the ionic current to the charge movement in the cardiac calcium channel," Science 262, 575-578.
58. Pepin, M. C., Yue, S. Y., Roberts, E., Wahlestedt, C., and Walker, P. (1997). "Novel 'restoration of function' mutagenesis strategy to identify amino acids of the della-opioid receptor involved in ligand binding," J. Biol. Chem. 272, 9260-9267.
59. Perez-Reyes, E., and Schneider, T. (1995). "Molecular biology of calcium channels," Kidney Int. 48, 1111-1124.
60. Perez-Garcia, M. T., Kamp, T. and Marban, E. (1995). "Functional properties of cardiac L-Type calcium channels transiently expressed in HEK293 cells," J. Gen. Physiol. 105, 289-306.
61. Peterson, B. Z., and Catterall, W. A. (1995). "Calcium binding in the pore of L-type calcium channels modulates high-affinity dihydropyridine binding," J. Biol. Chem. 270, 18201-18204.
62. Peterson, B. Z., Tanada, T. N., and Catterall, W. A. (1996). "Molecular determinants of high-affinity dihydropyridine binding in L-type calcium channels," J. Biol. Chem. 271, 5293-5296.
63. Peterson, B. Z., Johnson, B. D., Hockerman, G. H., Acheson, M., Scheuer, T., and Catterall, W. A. (1997). "Analysis of the dihydropyridine receptor site of L-type calcium channels by alanine-scanning mutagenesis," J. Biol. Chem. 272, 18752-18758.
64. Postina, R., Kojro, E., and Fahrenholz, F. (1996). "Separate agonist and peptide antagonist binding sites of the oxytocin receptor defined by their transfer into the V2 vasopressin receptor," J. Biol. Chem. 271, 31593-31601.
65. Prinz, H., and Striessnig, J. (1993). "Ligand-induced accelerated dissociation of ( + )-cis-diltiazem from L-type calcium-channels is simply explained by competition for individual attachment points," J. Biol. Chem. 268, 18580-18585.
66. + channels by local anesthetics," Science 265, 1724-1728.
67. Regulla, S., Schneider, T., Nastainczyk, W., Meyer, H. E., and Hofmann, F. (1991). "Identification of the site of interaction of the dihydropyridine channel blockers nitrendtpine and azidopine with the calcium-channel alpha 1 subunit," EMBO J. 10, 45-49.
68. 1B calcium channels by co-expression of the β subunit." FEBS Lett. 371, 43-46.
69. Schuster, A., Lacinova, L., Klugbauer, N., Ito, H., Birnbaumer, L., and Hofmann, F. (1996). "The IVS6 segment of the L-type calcium channel is critical for the action of dihydropyridines and phenylalkylamines," EMBO J. 15, 2365-2370.
70. Sinnegger, M. J., Wang, Z., Grabner, M., Hering, S., Striessnig, J., Glossmann, H., and Mitterdorfer, J. (1997). "Nine L-type amino acid residues confer full 1,4-dihydropyridine sensitivity to the neuronal calcium channel alpha 1A subunit: role of L-type methionine-1188," J. Biol. Chem. 272, 27686-27693.
71. 2+ antagonist binding sites," Eur. J. Biochem. 150, 67-77.
72. Striessnig, J., Knaus, H. G., Grabner, M., Moosburger, K., Seitz, W., Lietz, H., and Glossmann, H. (1987). "Photoaffinity labelling of the phenylalkylamine receptor of the skeletal muscle transverse-tubule calcium channel," FEBS Lett. 212, 247-253.
73. Striessnig, J., Knaus, H. G., and Glossmann, H. (1988). "Photoaffinity-labelling of the calcium-channel-associated 1,4-dihydropyridine and phenylalkylamine receptor in guinea-pig hippocampus." Biochem. J. 253, 39-47.
74. 2+ channels," Proc. Natl. Acad. Sci. USA 87, 9108-9112.
75. Striessnig, J., Scheffauer, F., Mitterdorfer, J., Schirmer, M., and Glossmann, H. (1990b). "Identification of the benzothiazepine-binding polypeptide of skeletal muscle calcium channels with ( + )-cis-azidodiltiazem and anti-ligand antibodies," J. Biol. Chem. 265, 363-370.
76. 3H]azidopine within the alpha 1 subunit," Proc. Natl. Acad. Sci. USA 88, 10769-10773.
77. Strübing, C., Hering, S., and Glossmann, H. (1993). "Evidence for an external location of the dihydropyridine agonist receptor site on smooth muscle and skeletal muscle calcium channels. Br. J. Pharmacol. 108, 884-891.
78. Tanabe, T., Takeshima, H., Mikami, A., Flockerzi, V., Takahashi, H., Kangawa, K., Kojima, M., Matsuo, H., Hirose, T., and Numa, S. (1987). "Primary structure of the receptor for calcium channel blocker from skeletal muscle," Nature 328, 313-318.
79. Tang, S., Mikala, G., Bahinski, A., Yatani, A., Varadi, G., and Schwartz, A. (1993). "Molecular localization of ion selectivity sites within the pore of a human L-type cardiac calcium channel." J. Biol. Chem. 268, 13026-13029.
80. Tejedor, F. J., and Catterall, W. A. (1988). "Site of covalent attachment of alpha-scorpion toxin derivatives in domain I of the sodium channel alpha subunit," Proc. Natl. Acad. Sci. USA 85, 8742-8746.
81. Trainer, V. L., Baden, D. G., and Catterall, W. A. (1994). "Identification of peptide components of the brevetoxin receptor site of rat brain sodium channels." J. Biol. Chem. 269, 19904-19909.
82. Trainer, V. L., Brown, G. B., and Catterall, W. A. (1996). "Site of covalent labeling by a photoreactive batrachotoxin derivative near transmembrane segment IS6 of the sodium channel alpha subunit," J. Biol. Chem. 271, 11261-11267.
83. Tsien, R. W., Hess, P., McCleskey, E. W., and Rosenberg, R. L. (1987). "Calcium channels: mechanisms of selectivity, permeation, and block," Annu. Rev. Biophys. Biophys. Chem. 16, 265-290.
84. Wegener, J. W., and Nawrath, H. (1995). "Extracellular site of action of phenylalkylamines on L-type calcium current in rat ventricular myocytes," Naunyn Schmiedebergs Arch. Pharmacol. 352, 322-330.
85. 2+ channel pharmacology. Subunit requirement for the high-affinity and allosteric regulation of dihydropyridine binding," J. Biol, Chem. 270, 27106-27111.
86. 2+ channels," Nature 366, 158-161.
87. Zhang, J. F., Ellinor, P. T., Aldrich, R. W., and Tsien, R. W. (1994). "Molecular determinants of voltage-dependent inactivation in calcium channels," Nature 372, 97-100.
88. 2+ ions and dihydropyridine ligand," Biophys. J. 70, 22-37.
89. Zong, S., Zhou, J., and Tanabe, T. (1994). "Molecular determinants of calcium-dependent inactivation in cardiac L-type calcium channels," Biochem. Biophys. Res. Commun. 201, 1117-1123.